NCT02738580View on ClinicalTrials.gov

Follicular Steroid Genesis in Controlled Ovarian Stimulation

PHASE4CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

October 18, 2016

Primary Completion Date

June 15, 2018

Study Completion Date

June 15, 2018

Conditions
InfertilityControlled Ovarian Hyperstimulation
Interventions
DRUG

COS with GnRH antagonists and rFSH

Controlled ovarian hyperstimulation with GnRH antagonists and rFSH in women with normal ovarian function.

DRUG

COS with GnRH antagonists and HP-HMG

Controlled ovarian hyperstimulation with GnRH antagonists and HP-HMG in women with normal ovarian function.

Trial Locations (1)

46015

IVI Valencia, Valencia

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Instituto Valenciano de Infertilidad, IVI VALENCIA

OTHER

NCT02738580 - Follicular Steroid Genesis in Controlled Ovarian Stimulation | Biotech Hunter | Biotech Hunter